Get the Stockscreener App
11.78
5.46%
-0.68
Celcuity Inc stock is traded at $11.78, with a volume of 147.40K.
It is down -5.46% in the last 24 hours and up +11.03% over the past month.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
See More
Previous Close:
$12.46
Open:
$12.39
24h Volume:
147.40K
Relative Volume:
0.65
Market Cap:
$489.23M
Revenue:
-
Net Income/Loss:
$-63.78M
P/E Ratio:
-4.3955
EPS:
-2.68
Net Cash Flow:
$-53.91M
1W Performance:
-8.82%
1M Performance:
+11.03%
6M Performance:
-6.14%
1Y Performance:
-19.37%
1-Day Range:
$11.78
$12.47
1-Week Range:
$11.78
$12.96
52-Week Range:
$7.575
$19.77
Celcuity Inc Stock (CELC) Company Profile
Name
Celcuity Inc
Sector
Industry
Phone
763-392-0767
Address
16305 36TH AVENUE N, MINNEAPOLIS, MN
Compare CELC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CELC
Celcuity Inc
|
11.78 | 489.23M | 0 | -63.78M | -53.91M | -2.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.99 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
508.86 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.71 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
540.71 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
254.09 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Celcuity Inc Stock (CELC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-22-24 | Initiated | Leerink Partners | Outperform |
| Feb-22-24 | Initiated | Stifel | Buy |
| Dec-08-23 | Initiated | H.C. Wainwright | Buy |
| Oct-08-21 | Initiated | Canaccord Genuity | Buy |
| Sep-07-21 | Initiated | Jefferies | Buy |
| Jul-29-21 | Initiated | Cowen | Outperform |
| Jul-27-21 | Initiated | Needham | Buy |
| Jan-28-21 | Reiterated | H.C. Wainwright | Buy |
| Dec-24-20 | Reiterated | H.C. Wainwright | Buy |
| May-11-20 | Resumed | Craig Hallum | Buy |
| Nov-20-18 | Initiated | H.C. Wainwright | Buy |
View All
Celcuity Inc Stock (CELC) Latest News
Analysts Set Celcuity Inc. (NASDAQ:CELC) Price Target at $30.80 - Defense World
Wealth Enhancement Advisory Services LLC Grows Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World
Stocks in play: Roots Corp. - The Globe and Mail
(CELC) Trading Advice - news.stocktradersdaily.com
Celcuity projects $2B revenue potential for gedatolisib in second-line breast cancer market - MSN
Celcuity Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - Revista ADVFN
Cisco Powers AI-Ready Data Centers, From Hyperscale to Enterprise - The Globe and Mail
Millennium Management LLC Has $519,000 Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World
Two Sigma Investments LP Has $679,000 Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World
Nuveen Asset Management LLC Grows Position in Celcuity Inc. (NASDAQ:CELC) - Defense World
Ballard announces 1.5 MW fuel cell engine order for Sierra Northern Railway - The Globe and Mail
Citadel Advisors LLC Buys New Stake in HUHUTECH International Group Inc. (NASDAQ:HUHU) - Defense World
Two Sigma Advisers LP Decreases Stock Position in Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity Inc. (NASDAQ:CELC) Shares Sold by BNP Paribas Financial Markets - Defense World
Celcuity Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update - ACCESS Newswire
BMO Lowers Fees on Asset Allocation ETFs to Deliver Greater Value to Investors - The Globe and Mail
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $258,000 Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World
Deutsche Bank AG Purchases 9,174 Shares of Celcuity Inc. (NASDAQ:CELC) - Defense World
Cetera Investment Advisers Trims Position in Franklin Limited Duration Income Trust (NYSEAMERICAN:FTF) - Defense World
Precigen, Inc. (NASDAQ:PGEN) Shares Acquired by Cetera Investment Advisers - Defense World
BlackRock Floating Rate Income Strategies Fund, Inc. (NYSE:FRA) Shares Acquired by Cetera Investment Advisers - Defense World
Schwab U.S. REIT ETF (NYSEARCA:SCHH) Stock Holdings Raised by Bank of America Corp DE - Defense World
Citadel Advisors LLC Sells 24,240 Shares of Goldman Sachs Access Inflation Protected USD Bond ETF (BATS:GTIP) - Defense World
BNP Paribas Financial Markets Sells 19,586 Shares of NovaGold Resources Inc. (NYSEAMERICAN:NG) - Defense World
Bank of America Corp DE Has $3.77 Million Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World
H-CYTE (OTCMKTS:HCYTD) Stock Price Down 49.5% – What’s Next? - Defense World
Celcuity at TD Cowen’s Oncology Summit: Exploring Gadotelisib’s Potential By Investing.com - Investing.com Canada
Celcuity at TD Cowen’s Oncology Summit: Exploring Gadotelisib’s Potential - Investing.com India
Tourmaline Oil (OTCMKTS:TRMLF) Stock Price Up 1.9% – What’s Next? - Defense World
AIB Group (OTCMKTS:AIBRF) Stock Price Up 0.3% – Here’s Why - Defense World
FIBRA Prologis (OTCMKTS:FBBPF) Stock Price Down 1.1% – Here’s Why - Defense World
HELLA GmbH & Co. KGaA (OTCMKTS:HLLGY) Shares Down 1.1% – Here’s What Happened - Defense World
Secure Energy Services (OTCMKTS:SECYF) Shares Up 3.2% – What’s Next? - Defense World
Husky Energy (OTCMKTS:HUSKF) Stock Price Up 7% – Still a Buy? - Defense World
Exicure (NASDAQ:XCUR) Trading Down 4.5% – Here’s Why - Defense World
Namaste Technologies (CVE:N) Trading 6.9% Higher – Time to Buy? - Defense World
Virtus InfraCap U.S. Preferred Stock ETF (NYSEARCA:PFFA) Shares Down 0.1% – Here’s What Happened - Defense World
Lundin Gold (OTCMKTS:FTMNF) Shares Up 4.3% – What’s Next? - Defense World
Roche (OTCMKTS:RHHVF) Stock Price Up 0.4% – Still a Buy? - Defense World
GraniteShares XOUT U.S. Large Cap ETF (NYSEARCA:XOUT) Trading Down 1% – Here’s What Happened - Defense World
FinServ Acquisition (OTCMKTS:FSRVU) Trading 7.9% Higher – Still a Buy? - Defense World
D. E. Shaw & Co. Inc. Sells 13,666 Shares of Tompkins Financial Co. (NYSEAMERICAN:TMP) - Defense World
Ameriprise Financial Inc. Has $5.85 Million Stock Holdings in Celcuity Inc. (NASDAQ:CELC) - Defense World
Celcuity Inc. (NASDAQ:CELC) Shares Bought by Northern Trust Corp - Defense World
Q1 Earnings Estimate for Celcuity Issued By HC Wainwright - Defense World
HC Wainwright Analysts Lift Earnings Estimates for Celcuity - Defense World
Brokerages Set Celcuity Inc. (NASDAQ:CELC) Target Price at $30.80 - Defense World
Celcuity Presents Updated Results from Phase 1b Study of Gedatolisib in Treatment-Naïve Patients at the 2023 ESMO Breast Cancer Annual Congress - ACCESS Newswire
How To Trade (CELC) - news.stocktradersdaily.com
Celcuity To Present at Upcoming TD Cowen and Jefferies Investor Conferences - GlobeNewswire
Celcuity’s (CELC) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Celcuity Inc Stock (CELC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):